Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Victor Genestier"'
Autor:
Tassia Cristina Decimoni, Adriana Cury, James Farrell, Nicolas Bertin, Claire Fischer, Victor Genestier, Jorge Vaz Pinto Neto, Glaciano Ribeiro, Angelo Maiolino
Publikováno v:
HemaSphere, Vol 7, p e02764d2 (2023)
Externí odkaz:
https://doaj.org/article/eba047341cab431aa8bda035476776f5
Autor:
Faisal M Sanai, Hamdan Alghamdi, Khalid A Alswat, Mohammed A Babatin, Mona H Ismail, Waleed K Alhamoudi, Abduljaleel M Alalwan, Yaser Dahlan, Abdullah S Alghamdi, Faleh Z Alfaleh, Abdulrahman A Aljumah, Ibrahim H Altraif, Khalid Albeladi, Faisal Batwa, Waleed Alshumrani, Drifa Belhadi, Victor Genestier, Ayman A Abdo
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 25, Iss 3, Pp 194-200 (2019)
Background/Aims: Middle Eastern countries, including Saudi Arabia to some extent, are endemic for chronic hepatitis B (CHB) infection which could be associated with high mortality and comorbidities risk. However, limited data characterizing this CHB
Externí odkaz:
https://doaj.org/article/b899c6d82cff4542bbf64da88066d2bb
Autor:
Talha Munir, Victoria Genovez, Victor Genestier, Kellie Ryan, Bengt Liljas, Priyanka Gaitonde
Clinical outcomes in chronic lymphocytic leukemia (CLL) have improved with targeted therapy, including Bruton tyrosine kinase inhibitors such as acalabrutinib. A semi-Markov model with three health states (progression-free, progressed disease, and de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10618168ee4a85942cd60520b74712de
Autor:
Faleh Z. Al-Faleh, Ayman A. Abdo, Waleed Al-Hamoudi, Waleed Alshumrani, Drifa Belhadi, Hamdan S. Alghamdi, Khalid Alswat, Abdullah S. Alghamdi, Mohammed A. Babatin, Faisal M. Sanai, Faisal Batwa, Khalid Albeladi, Yaser Dahlan, Ibrahim Altraif, Mona H Ismail, Abduljaleel M. Alalwan, Abdulrahman Aljumah, Victor Genestier
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 25, Iss 3, Pp 194-200 (2019)
Background/Aims: Middle Eastern countries, including Saudi Arabia to some extent, are endemic for chronic hepatitis B (CHB) infection which could be associated with high mortality and comorbidities risk. However, limited data characterizing this CHB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b69da97b1e9da2790b81fd6d32a8c4
https://doi.org/10.4103/sjg.sjg_447_18
https://doi.org/10.4103/sjg.sjg_447_18
Autor:
Munir, Talha, Genovez, Victoria, Genestier, Victor, Ryan, Kellie, Liljas, Bengt, Gaitonde, Priyanka
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research; Jun2023, Vol. 23 Issue 5, p579-589, 11p
Autor:
Decimoni, Tassia Cristina, Cury, Adriana, Farrell, James, Bertin, Nicolas, Fischer, Claire, Genestier, Victor, Neto, Jorge Vaz Pinto, Ribeiro, Glaciano, Maiolino, Angelo
Publikováno v:
HemaSphere; 2023 Supplement 3, Vol. 7, pe02764d2-e02764d2, 1p
Autor:
Johal S; Oncology Market Access and Pricing, AstraZeneca, Cambridge, UK., Brannman L; Oncology Market Access and Pricing, AstraZeneca, Gaithersburg, MD, USA., Genestier V; Health Economic and Outcomes Research, Amaris Consulting, Toronto, Ontario, Canada., Cawston H; Health Economic Outcomes Research, Amaris Consulting, Paris, France.
Publikováno v:
ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2024 Feb 28; Vol. 16, pp. 97-109. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).